Biblio

Author Title [ Type(Desc)] Year
Filters: Author is Ong, Choon Kiat  [Clear All Filters]
Journal Article
Chen J, Zuo Z, Gao Y, Yao X, Guan P, Wang Y, Li Z, Liu Z, Hong JHan, Deng P, et al. Aberrant JAK-STAT signaling-mediated chromatin remodeling impairs the sensitivity of NK/T-cell lymphoma to chidamide. Clin Epigenetics. 2023;15(1):19.
Chan JYongsheng, Somasundaram N, Grigoropoulos N, Lim F, Poon MLimei, Jeyasekharan A, Yeoh KWei, Tan D, Lenz G, Ong CKiat, et al. Evolving therapeutic landscape of diffuse large B-cell lymphoma: challenges and aspirations. Discov Oncol. 2023;14(1):132.
Goh J, De Mel S, Hoppe MM, Rashid MBte Mohd A, Zhang XYun, Jaynes P, Ng EKa Yan, Rahmat N'ADiana Bint, Liu CXin, Poon L, et al. An ex vivo platform to guide drug combination treatment in relapsed/refractory lymphoma. Sci Transl Med. 2022;14(667):eabn7824.
Lim WKhong, Ong CKiat, Tan J, Thike AAye, Ng CChuan Youn, Rajasegaran V, Myint SSwe, Nagarajan S, Nasir NDiyana Md, McPherson JR, et al. Exome sequencing identifies highly recurrent MED12 somatic mutations in breast fibroadenoma. Nat Genet. 2014.
Cutcutache I, Suzuki Y, Tan IBeehuat, Ramgopal S, Zhang S, Ramnarayanan K, Gan A, Lee HHong, Tay STing, Ooi A, et al. Exome-wide Sequencing Shows Low Mutation Rates and Identifies Novel Mutated Genes in Seminomas. Eur Urol. 2015.
Chen J, Hong JHan, Huang Y, Liu S, Yin J, Deng P, Sun Y, Yu Z, Zeng X, Xiao R, et al. EZH2 mediated metabolic rewiring promotes tumor growth independently of histone methyltransferase activity in ovarian cancer. Mol Cancer. 2023;22(1):85.
Tan J, Ong CKiat, Lim WKhong, Ng CChuan Youn, Thike AAye, Ng LMoy, Rajasegaran V, Myint SSwe, Nagarajan S, Thangaraju S, et al. Genomic landscapes of breast fibroepithelial tumors. Nat Genet. 2015.
Kongpetch S, Jusakul A, Ong CKiat, Lim WKhong, Rozen SG, Tan P, Teh BTean. Pathogenesis of cholangiocarcinoma: From genetics to signalling pathways. Best Pract Res Clin Gastroenterol. 2015;29(2):233-244.
Hoppe MMarek, Jaynes P, Shuangyi F, Peng Y, Sridhar S, Hoang PMai, Liu CXin, De Mel S, Poon L, Chan EHian Li, et al. Patterns of Oncogene Coexpression at Single-Cell Resolution Influence Survival in Lymphoma. Cancer Discov. 2023:OF1-OF20.
Wang Y, Zhou W, Chen J, Chen J, Deng P, Chen H, Sun Y, Yu Z, Pang D, Liu L, et al. Preclinical characterization of WB737, a potent and selective STAT3 inhibitor, in natural killer/T-cell lymphoma. MedComm (2020). 2023;4(4):e284.
Zhou J, Toh SHui-Min, Tan TKing, Balan K, Lim JQuan, Tan TZea, Xiong S, Jia Y, Ng S-B, Peng Y, et al. Super-enhancer-driven TOX2 mediates oncogenesis in Natural Killer/T Cell Lymphoma. Mol Cancer. 2023;22(1):69.
Lim SKiat, Peng CChen, Low S, Vijay V, Budiman A, Phang BHooi, Lim JQuan, Jeyasekharan AD, Lim SThye, Ong CKiat, et al. Sustained activation of non-canonical NF-κB signalling drives glycolytic reprogramming in doxorubicin-resistant DLBCL. Leukemia. 2022.